衰弱对心血管疾病特异性健康状况的影响
本综述总结了衰弱对不同心血管疾病健康状况结局的影响。在心力衰竭和瓣膜病中,衰弱患者疾病特异性健康状况明显受损,但干预后健康状况改善相似甚至更大;衰弱不应作为不治疗的依据。冠心病、外周动脉疾病和房颤中衰弱对健康状况影响的数据有限,需进一步研究。
要点
- 心衰衰弱患者健康状况明显受损,但干预后改善相似或更大。
- 瓣膜病衰弱增加术后不良健康状况风险,但无证据支持优先选择某种术式。
- 健康状况改善可能逆转衰弱,不应仅因衰弱而 withholding 治疗。
核心结论
- 衰弱对心血管疾病特异性健康状况的影响因疾病类型而异,且不应仅凭衰弱存在而拒绝治疗。
研究设计与样本
- 综述,总结衰弱对不同心血管疾病健康状况结局的影响。
主要发现
- 心衰衰弱患者疾病特异性健康状况明显受损,且面临后续健康状况恶化风险。
- 心衰衰弱患者经心脏康复或指南导向药物治疗后健康状况改善相似甚至更大。
- 瓣膜病衰弱增加经导管主动脉介入或外科主动脉瓣置换术后不良健康状况风险,但无证据支持衰弱患者从某术式中获益更多。
- 心衰和瓣膜病中健康状况改善可能逆转衰弱。
- 冠心病、外周动脉疾病和房颤中衰弱对健康状况影响的数据有限。
临床怎么用
- 不应仅因衰弱存在而 withheld 对心衰或瓣膜病的治疗。
- 对心衰衰弱患者,心脏康复或指南导向药物治疗可改善健康状况。
局限性
- 冠心病、外周动脉疾病和房颤中衰弱对健康状况影响的数据有限,需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Frailty is a syndrome of older age that reflects an impaired physiological reserve and decreased ability to recover from medical stressors. While the impact of frailty on mortality in cardiovascular disease has been well described, its impact on cardiovascular disease-specific health status-cardiac symptoms, physical functioning and quality of life-has been less well studied. In this review, we summarise the impact of frailty on health status outcomes across different cardiovascular conditions. In heart failure, frail patients have markedly impaired disease-specific health status and are at risk for subsequent health status deteriorations. However, frail patients have similar or even greater health status improvements with interventions for heart failure, such as cardiac rehabilitation or guideline-directed medical therapy. In valvular heart disease, the impact of frailty on disease-specific health status is of even greater concern since management involves physiologically taxing procedures that can worsen health status. Frailty increases the risk of poor health status outcomes after transcatheter aortic valve intervention or surgical aortic valve replacement for aortic stenosis, but there is no evidence that frail patients benefit more from one procedure versus another. In both heart failure and valvular heart disease, health status improvements may reverse frailty, highlighting the overlap between cardiovascular disease and frailty and emphasising that treatment should typically not be withheld based on the presence of frailty alone. Meanwhile, data are limited on the impact of frailty on health status outcomes in the treatment of coronary artery disease, peripheral artery disease and atrial fibrillation, and requires further research.
引用
- Nguyen DD, Arnold SV. Impact of frailty on disease-specific health status in cardiovascular disease. Heart. 2023. PMID: 36604164. doi:10.1136/heartjnl-2022-321631
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。